Latanoprost
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2354 publications
Emerging topical nonsteroidal therapies in pediatric dermatology: atopic dermatitis, psoriasis, alopecia areata, vitiligo, and seborrheic dermatitis.
Journal: Current opinion in pediatrics
Published: June 04, 2026
Phakic Intraocular Lenses as a Potential Treatment for Pigment Dispersion Syndrome.
Journal: Cureus
Published: April 12, 2026
Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy.
Journal: medRxiv : the preprint server for health sciences
Published: April 01, 2026
Ciliary muscle thickness and intraocular pressure before and after latanoprost.
Journal: Optometry and vision science : official publication of the American Academy of Optometry
Published: March 13, 2026
Anterior segment, static and dynamic pupillography changes in patients with primary open-angle glaucoma using different types of topical antiglaucomatous agents.
Journal: Photodiagnosis and photodynamic therapy
Published: March 02, 2026
Photophobia in a young patient with atonic pupils and iris transillumination
Journal: Die Ophthalmologie
Published: February 13, 2026
A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: January 12, 2026
Comparison of Preservative-Free and Preserved Latanoprost in Primary Open-Angle Glaucoma: A Randomized Crossover Study.
Journal: Korean journal of ophthalmology : KJO
Published: January 11, 2026
Sustained intraocular pressure lowering from suprachoroidal injection of a latanoprost lipid nanoparticle delivery system in the rabbit.
Journal: Frontiers in medicine
Published: December 28, 2025
The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost, a Novel Dual Agonist of FP and EP3 Receptors, in Monkeys.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: December 20, 2025
Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study.
Journal: Japanese journal of ophthalmology
Published: December 10, 2025
Phase III Prospective Randomised Study of Netarsudil and Concomitant Latanoprost Efficacy and Safety for Primary Open-Angle Glaucoma or Ocular Hypertension in Japan: J-ROCKET-2.
Journal: Advances in therapy
Published: December 08, 2025
Last Updated: 06/30/2026